Onkologie. 2011:5(2):83-86
Benign and malignant tumours of the spine and spinal cord are frequent findings and cause major morbidity (pain and neurological
deficit) which significantly impairs the quality of life. The incidence of metastatic skeletal disease is approximately 6,500 new cases per
year in the Czech Republic and, given a longer survival rate than that observed in the case of visceral metastases, it poses a major health
problem. The treatment for spinal tumours usually requires a multidisciplinary approach. In some cases, a complete removal is possible
whereas sometimes decompression is all that can be done. Conventional external radiotherapy is commonly limited by the tolerance
dose of the spinal cord, which may result in inadequate local control. Stereotactic radiosurgery (SRS) using the CyberKnife system is
distinguished from external fractionated radiotherapy by the use of multiple convergent fields which allow delivery of a high dose of
radiation to the target volume while sparing the surrounding structures. Intracranial SRS has been used for a relatively long time with
a single high dose of radiation being delivered (in the order of tens of Gy). In extracranial sites, the use of a few fractions (2–5) has been
shown as more convenient which is why the term radiosurgery has proved as not quite adequate. In the English literature, the term
SBRT (Stereotactic body radiotherapy) is being increasingly replaced by the term Stereotactic Ablative Body Radiotherapy (SABR) which
accurately reflects the true nature of this method.
Published: April 1, 2011 Show citation